| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8295870 | Biochemical and Biophysical Research Communications | 2017 | 24 Pages | 
Abstract
												TGF-β type III receptor (TβRIII) is a co-receptor for TGFβ family members required for high-affinity binding of these ligands to their receptors, potentiating their cellular functions. TGF-βs, Bone Morphogenetic Proteins (BMP2/4) and Inhibins/Activins regulate different checkpoints during T cell differentiation. We have previously reported that TβRIII modulates T cell development by protecting developing thymocytes from apoptosis, however the role of this co-receptor in peripheral lymphocytes still remains elusive. Here we describe a detailed characterization of TβRIII expression in murine and human lymphocyte subpopulations demonstrating that this co-receptor is significantly expressed in T but not B lymphocytes and among them, preferentially expressed on naïve and central memory T cells. TβRIII was upregulated after TCR stimulation, in parallel to other early activation markers. In contrast, natural and induced Tregs downregulated TβRIII in association with FoxP3 upregulation. Finally, anti-TβRIII blocking experiments demonstrated that TβRIII promotes TGFβ-dependent iTreg conversion in vitro, and suggest that this co-receptor may be involved in modulating peripheral T cell tolerance and could be considered as a potential target to boost T cell immune responses.
											Keywords
												
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Biochemistry
												
											Authors
												Sandra Ortega-Francisco, Marisol de la Fuente-Granada, Evelyn K. Alvarez Salazar, Lizbeth Airais Bolaños-Castro, Gabriela Fonseca-Camarillo, Roxana Olguin-Alor, Germán R. Alemán-Muench, Fernando López-Casillas, Chander Raman, 
											